Horizon Pharma (Nasdaq: HZNP) announced a proposal to acquire all outstanding shares of Depomed, Inc. (Nasdaq: DEPO) for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE